California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Russia tests nuclear-powered cruise missile, experts raise concerns over technical issues and contamination risks.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
California Governor Gavin Newsom is seriously considering a 2028 presidential run, but will wait until after the 2026 midterms to make a final decision.
Russia tests nuclear-powered cruise missile, experts raise concerns over technical issues and contamination risks.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.